Diabetes insipidus in craniopharyngioma: Postoperative management of water and electrolyte disorders

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue SUPPL. 1, 2006, Pages 413-421

  Ghirardello, Stefano ^a   Hopper, Neil ^b   Albanese, Assunta ^b   Maghnie, Mohamad ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Craniopharyngioma; Diabetes; Insipidus; Surgical complications

Indexed keywords

ADENOSINE PHOSPHATE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROPAMIDE; CLOFIBRATE; CORTICOSTEROID; CYCLOSPORIN A; CYTOTOXIC AGENT; DEMECLOCYCLINE; DESMOPRESSIN; DIURETIC AGENT; FLUDROCORTISONE ACETATE; FUROSEMIDE; LAMOTRIGINE; LITHIUM CARBONATE; MINERALOCORTICOID; OPIATE DERIVATIVE; SEDATIVE AGENT; SODIUM; SODIUM CHLORIDE; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ADIPSIA; BRAIN EDEMA; CENTRAL PONTINE MYELINOLYSIS; CHILDHOOD CANCER; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; CORTICOTROPIN DEFICIENCY; CRANIOPHARYNGIOMA; DEATH; DEMYELINATING DISEASE; DIABETES INSIPIDUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DIURESIS; DOSE RESPONSE; DRUG EXCRETION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG PROTEIN BINDING; ELECTROLYTE BALANCE; ELECTROLYTE DISTURBANCE; FLUID THERAPY; HUMAN; HYPERNATREMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; INTERMETHOD COMPARISON; LOW DRUG DOSE; NATRIURESIS; PATHOPHYSIOLOGY; POLYURIA; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; SURGICAL APPROACH; SURGICAL RISK; TRANSSPHENOIDAL SURGERY; URINE VOLUME; VASOPRESSIN RELEASE; WATER DEFICIT; WATER DEPRIVATION; WATER INTOXICATION;

CHILD; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; HUMANS; HYPONATREMIA; NEUROSURGICAL PROCEDURES; PITUITARY NEOPLASMS; POSTOPERATIVE COMPLICATIONS; THIRST; VASOPRESSINS; WATER-ELECTROLYTE IMBALANCE;

EID: 33646170878     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Chen C, Okera S, Davies PE, Seva D, Crompton JL. Craniopharyngioma: a review of long-term visual outcome. Clin Exp Ophthalmol 2003; 31: 220-228.
2. Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN, Shu H-K. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 2004; 58: 714-720.
3. Müller HL, Handwerker G, Wollny B, Faldum A, Sörensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 2002; 87: 3993-3996.
4. Larijani B, Bastanhagh MH, Pajouhi M, Shadab FK, Vasigh A, Agakhani S. Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care 2003; 13: 11-15.
5. Lehrnbecher T, Müller-Scholden J, Danhauser-Leistner I, Sörensen N, von Stockhausen H-B. Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. Childs Nerv Syst 1998; 14: 276-279.
6. Laws ER Jr, Thapar K. The diagnosis and management of craniopharyngioma. Genet GH 1994; 10: 6-10.
7. de Vries L, Lazar L, Phillip M. Craniopharyngioma: presentation and endocrine sequelae in children. J Pediatr Endocrinol Metab 2003; 16: 703-710.
8. Gonc EN, Yordam N, Ozon A, Alinkasifoglu A, Kandemir N. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases. Pediatr Neurosurg 2004; 40: 112-119.
9. De Vile CJ, Grant DB, Kendall BE, Neville BG, Stanhope R, Watkins KE, Hayward RD. Management of childhood craniopharyngioma: Can the morbidity of radical surgery be predicted? J Neurosurg 1996; 85: 73-81.
10. Randall RV, Clark EC, Dodge HW Jr, Love JG. Polyuria after operation for tumors in the region of the hypophysis and hypothalamus. J Clin Endocrinol Metab 1960; 20: 1614-1621.
11. Matarazzo P, Genitori L, Lala R, Andreo M, Grossetti R, de Sanctis C. Endocrine function and water metabolism in children and adolescents with surgically treated intra/parasellar tumors. J Pediatr Endocrinol Metab 2004; 17: 1487-1495.
12. Seckl JR, Dunger DB, Bevan JS, Nakasu Y, Chowdrey C, Burke CW, Lightman SL. Vasopressin antagonist in early postoperative diabetes insipidus. Lancet 1990; 355: 1353-1356.
13. Albanese A, Hindmarsh P, Stanhope R. Management of hyponatraemia in patients with acute cerebral insults. Arch Dis Child 2001; 85: 246-251.
14. McDonald JA, Martha PM Jr, Kerrigan J, Clarke WL, Rogol AD, Blizzard RM. Treatment of the young child with postoperative central diabetes insipidus. Am J Dis Child 1989; 143: 201-204.
15. Yeates KE, Singer M, Morton AR. Salt and water: a simple approach to hyponatremia. CMAJ 2004; 170: 365-369.
16. Arieff AI. Treatment of hyponatremic encephalopathy with antagonist to antidiuretic hormone. J Lab Clin Med 2001; 138: 8-10.
17. Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab 2003; 14: 182-187.
18. Maesaka JK, Gupta S, Fishbane S. Cerebral salt-wasting syndrome: Does it exist? Nephron 1999; 82: 100-109.
19. Casulari LA, Costa KN, Albuquerque RC, Naves LA, Suzuki K, Domingues L. Differential diagnosis and treatment of hyponatremia following pituitary surgery. J Neurosurg Sci 2004; 48: 11-18.
20. McGirt MJ, Blessing R, Nimjee SM, Friedman AH, Alexander MJ, Laskowitz DT, Lynch JR. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004; 54: 1369-1373; discussion 1373-1374.
21. Seckl JR, Dunger DB, Bevan JS, Nakasu Y, Chowdrey C, Burke CW, Lightman SL. Vasopressin antagonist in early postoperative diabetes insipidus. Lancet 1990; 335: 1353-1356.
22. Kim RJ, Malattia C, Allen M, Moshang T, Maghnie M. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2004; 2 (Suppl 1): 115-123.
23. Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 2003; 35: 1495-1499.
24. Maghnie M, Genovese E, Lundin S, Bonetti F, Aricò M. Iatrogenic extrapontine myelinolysis in central diabetes insipidus: Are cyclosporin and 1-desamino-8-D-arginine vasopressin harmful in association? J Clin Endocrinol Metab 1997; 82: 1749-1751.
25. Kinik ST, Kandemir N, Baykan A, Akalan N, Yordam N. Fludrocortisone treatment in a child with severe cerebral salt wasting. Pediatr Neurosurg 2001; 35: 216-219.
26. Smith D, McKenna K, Moore K, Tormey W, Finucane J, Phillips J, Baylis P, Thompson CJ. Baroregulation of vasopressin release in adipsic diabetes insipidus. J Clin Endocrinol Metab 2002; 87: 4564-4568.
27. Smith D, Finucane F, Phillips J, Baylis PH, Finucane J, Tormey W, Thompson CJ. Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma. Clin Endocrinol (Oxf) 2004; 61: 273-279.
28. Rizzo V, Albanese A, Stanhope P. Morbidity and mortality associated with vasopressin replacement therapy in children. J Pediatr Endocrinol Metab 2001; 14: 861-867.